The West of England Commercialisation Academy was a free, eight-week programme designed to help promising health and care innovators navigate the complexities of commercialisation and move towards widespread adoption of their solutions. Delivered in partnership with Triple Chasm, the course provided innovators with strategic, data-driven frameworks to overcome barriers to adoption and scale their solutions across…
Read more
In partnership with the Somerset, Wiltshire, Avon and Gloucestershire Cancer Alliance, this pilot project evaluated the use of a minimally invasive capsule sponge test in primary care to improve the early detection of oesophageal cancer and Barrett’s oesophagus. By shifting diagnostics to GP practices, the initiative aims to catch the disease sooner and improve long-term…
Read more
We led the Medicines Safety Improvement Programme (MedSIP) in the West of England from 2022-2025, focused on addressing the widespread prescribing of opioids for long-term pain. While opioids are effective for acute and end-of-life pain, there is little evidence supporting their efficacy for chronic pain. However, their prescribing more than doubled between 1998 and 2018,…
Read more
Launched in April 2020, PERIPrem (Perinatal Excellence to Reduce Injury in Premature Birth) is a unique perinatal care bundle that aims to improve the outcomes for premature babies across the West and South West regions. PERIPrem reflects the NHS Long Term Plan ambition to reduce stillbirths, maternal and neonatal mortality and serious brain injury by…
Read more
Our project to improve care for patients receiving acute non-invasive ventilation (NIV) has helped to reduce mortality rates from 28% to 22% across the West of England, and modelling shows this approach has saved 165 lives to date. (NIV) services were developed in many UK hospitals after a clinical trial showed that it could reduce…
Read more
From November 2022 to March 2025, the PreCiSSIon programme successfully supported five acute maternity units in the West of England to achieve a 25% reduction in surgical site infection (SSI) rates following caesarean births by testing and reliably implementing evidence-based interventions at the time of surgery. As most SSIs occur after patient discharge from hospital,…
Read moreHealth Innovation West of England is part of the Royal United Hospitals Bath Foundation Trust. Health Innovation West of England is not responsible for the content of external sites. Read about our links to external sites.
